Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Zolmitriptan Dispersible Tablets

Approval Number

国药准字H20080825

Company开封制药（集团）有限公司

Registration Date

May 8, 2023

Drug Information

Generic Name

佐米曲普坦分散片

Brand Name

辅仁

Dosage Form

片剂

Strength

2.5mg

Drug Type

化学药品

Registration Date

May 8, 2023

Company Information

Applicant Company

Company Name开封制药（集团）有限公司

Company Address

开封市禹南街1号

Manufacturing Company

Company Name辅仁药业集团有限公司

Company Address

河南省鹿邑县产业集聚区同源路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy